Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Kenji Tanabe, M.D.

Co-Author

This page shows the publications co-authored by Kenneth Tanabe and Tatsuo Kawai.
Connection Strength

0.502
  1. Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival. J Gastrointest Surg. 2021 07; 25(7):1727-1735.
    View in: PubMed
    Score: 0.056
  2. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation. 1998 Jan 27; 65(2):224-8.
    View in: PubMed
    Score: 0.047
  3. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation. 1997 Dec 27; 64(12):1721-5.
    View in: PubMed
    Score: 0.046
  4. Graft-vs-host tolerance in mixed allogeneic chimerism. Transplant Proc. 1997 Feb-Mar; 29(1-2):1222-3.
    View in: PubMed
    Score: 0.044
  5. Long-term renal function after pregnancy in renal transplant recipients. Transplant Proc. 1997 Feb-Mar; 29(1-2):1567-8.
    View in: PubMed
    Score: 0.044
  6. Early diagnosis of CMV syndrome after kidney transplantation: comparison between CMV antigenemia and PCR assay. Transplant Proc. 1996 Jun; 28(3):1508-10.
    View in: PubMed
    Score: 0.042
  7. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. Transplant Proc. 1996 Jun; 28(3):1304-5.
    View in: PubMed
    Score: 0.042
  8. Long-term results of OKT3-treated renal transplant recipients. Transplant Proc. 1996 Jun; 28(3):1350-1.
    View in: PubMed
    Score: 0.042
  9. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation. Transplant Proc. 1996 Jun; 28(3):1447-8.
    View in: PubMed
    Score: 0.042
  10. [Urinary tract infection in kidney transplant recipients treated with ciclosporin]. Nihon Hinyokika Gakkai Zasshi. 1988 Feb; 79(2):246-53.
    View in: PubMed
    Score: 0.023
  11. New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2115-9.
    View in: PubMed
    Score: 0.022
  12. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation. 1997 Jun 15; 63(11):1616-9.
    View in: PubMed
    Score: 0.011
  13. Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients. Ther Apher. 1997 May; 1(2):191-4.
    View in: PubMed
    Score: 0.011
  14. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation. 1996 Jul 15; 62(1):126-8.
    View in: PubMed
    Score: 0.010
  15. Effect of interferon (IFN-alpha) for prevention of hepatitis C transmission from a seropositive donor to a seronegative recipient in renal transplantation. Transplant Proc. 1996 Jun; 28(3):1503-4.
    View in: PubMed
    Score: 0.010
  16. Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals. Transplant Proc. 1989 Feb; 21(1 Pt 1):937-40.
    View in: PubMed
    Score: 0.006
  17. Therapeutic effect of antiplatelet agents on obstructive vascular lesions after kidney transplantation with cyclosporine. Transplant Proc. 1987 Aug; 19(4 Suppl 5):77-81.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.